These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6601805)
1. Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein. Gralnick HR; Williams SB; Rick ME Proc Natl Acad Sci U S A; 1983 May; 80(9):2771-4. PubMed ID: 6601805 [TBL] [Abstract][Full Text] [Related]
2. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876 [TBL] [Abstract][Full Text] [Related]
3. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets. Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750 [TBL] [Abstract][Full Text] [Related]
4. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. Ruggeri ZM; Zimmerman TS J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982 [TBL] [Abstract][Full Text] [Related]
5. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity. Gralnick HR J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560 [TBL] [Abstract][Full Text] [Related]
6. Factor VIII/von Willebrand factor protein: sensitivity of periodic acid Schiff stain to carbohydrate deficiency. Gralnick HR; Jackson GM; Williams SB; Cregger MC Blood; 1982 Jun; 59(6):1310-6. PubMed ID: 6805533 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757 [TBL] [Abstract][Full Text] [Related]
8. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. Sultan Y; Simeon J; Caen JP J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003 [TBL] [Abstract][Full Text] [Related]
9. Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagen. Kessler CM; Floyd CM; Frantz SC; Orthner C Thromb Res; 1990 Jan; 57(1):59-76. PubMed ID: 2300925 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. Enayat MS; Hill FG J Clin Pathol; 1983 Aug; 36(8):915-9. PubMed ID: 6409946 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease. Zimmerman TS; Voss R; Edgington TS J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413 [TBL] [Abstract][Full Text] [Related]
13. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. Sodetz JM; Paulson JC; Pizzo SV; McKee PA J Biol Chem; 1978 Oct; 253(20):7202-6. PubMed ID: 100492 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
15. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268 [TBL] [Abstract][Full Text] [Related]
16. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Gill JC; Wilson AD; Endres-Brooks J; Montgomery RR Blood; 1986 Mar; 67(3):758-61. PubMed ID: 3484979 [TBL] [Abstract][Full Text] [Related]
17. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules. Furlan M; Perret BA; Beck EA Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738 [TBL] [Abstract][Full Text] [Related]
18. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor. Counts RB; Paskell SL; Elgee SK J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512 [TBL] [Abstract][Full Text] [Related]
20. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. Hamilton KK; Fretto LJ; Grierson DS; McKee PA J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]